Krystal Biotech Inc (KRYS)
Operating profit margin
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Operating income | US$ in thousands | 65,695 | -109,727 | -145,196 | -68,275 | -32,999 |
| Revenue | US$ in thousands | 296,569 | 55,764 | 498 | — | — |
| Operating profit margin | 22.15% | -196.77% | -29,155.82% | — | — |
December 31, 2024 calculation
Operating profit margin = Operating income ÷ Revenue
= $65,695K ÷ $296,569K
= 22.15%
Krystal Biotech Inc's operating profit margin has displayed significant fluctuations over the years. In December 31, 2020, and December 31, 2021, the operating profit margin was not available. However, the margin sharply declined to -29,155.82% by December 31, 2022, indicating a substantial operating loss relative to revenue.
The situation worsened in December 31, 2023, with the operating profit margin plummeting to -196.77%. This suggests that the company experienced heightened operational inefficiencies leading to a substantial negative impact on its profitability.
However, there was a marked improvement by December 31, 2024, with the operating profit margin turning positive at 22.15%. This indicates that the company managed to enhance its operational efficiency and control costs effectively, resulting in a stronger bottom-line performance.
Overall, the fluctuating trend in the operating profit margin for Krystal Biotech Inc highlights the company's challenges in maintaining profitability, but the recent improvement signals a positive turnaround in its operational performance.
Peer comparison
Dec 31, 2024